Beginning July 1, the CDC is offering weekly
one-hour videos that provide an overview of vaccination principles, general
best practices, immunization strategies, and specific information about
vaccine-preventable diseases and the vaccines that prevent them. Each video
will also include recent updates from the Advisory on Immunization Practices
The intended audience is all immunization providers, and continuing education will be available for each video. Due to COVID-19, the videos will be on demand and prerecorded rather than live. No registration is required, and videos will be released on Wednesdays through October 14. Videos can be accessed here.
The 2020 release schedule is below:
Principles of Vaccination
General Best Practice Guidelines, Part 1
General Best Practice Guidelines, Part 2, and Vaccine Safety
Vaccine Storage and Handling and Vaccine Administration
With the current challenges of getting
patients back into the office, it’s a great time to look into resources to help
connect with families. Sanofi Pasteur offers a helpful tool to deliver
important reminders to your patients. WellConnect is available at VaccineShoppe.com and has both text and voice
messaging capabilities. Sanofi Pasteur
created a helpful
WellConnect can be used for:
Flu and other immunization
Patient wellness checks and
Back-to-School health reminders
Medical screenings and health
In addition, WellConnect has a number of
helpful features such as survey capabilities and analytics. You can create an
account at VaccineShoppe.com as well as access
free resources and training materials. For more information, reach out to your
Dynavax is hosting a webinar on Hepatitis B presented
by: John Youhanna, PharmD, RPh, Regional Medical Director, Dynavax Technologies.
Now more than ever, it is important to prioritize the protection of healthcare workers who are at risk from infectious diseases, particularly hepatitis B, a potentially deadly virus that is spread through contact with infected blood and bodily fluids and can live on surfaces for at least seven days.1,2,3
Please join us to discuss why Hepatitis B is a current threat to our healthcare community and learn more about innovations in protection through vaccination.
This educational presentation will include a live Q & A session.
1 Centers for Disease Control and Prevention. Hepatitis B. In: Hamborsky J, Kroger A, Wolfe S, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Washington, DC: Public Health Foundation; 2015:149-174. https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/hepb.pdf. Accessed October16, 2017.
2. Walayat S, Ahmed Z, Martin D, Puli S, Cashman M, Dhillon S. Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine. World J Hepatol.2015;7(24):2503-2509. doi:10.4254/wjh.v7.i24.2503
3. Than TT, Jo E, Todt D, et al. High environmental stability of hepatitis B virus and inactivation requirements for chemical biocides. J Infect Dis. 2018 Oct 24. doi: 10.1093/infdis/jiy620. [Epub ahead of print].
Today kicks off National Infant Immunization Week (NIIW), a
yearly observance of the importance of vaccinating children two years and younger.
NIIW runs April 25-May 2, 2020 as part of World
Immunization Week, a World Health Organization Initiative. NIIW highlights
major achievements in the control of vaccine-preventable diseases and brings
attention to the challenges that remain. An overview of NIIW can be found here.
The CDC’s NIIW hub provides a wide variety of resources for
healthcare professionals to use during this week. The
Digital Media Toolkit has social media messages, content, and materials for
your practice to share. These include graphics pre-sized for Facebook,
Instagram, and Twitter. In addition, the Toolkit has flyers, posters,
infographics, and videos.
Sanofi Pasteur also has a helpful resources for creating a
culture of immunization called Developing an
Immunization Culture in Your Office. This handout breaks down broad ideas
concerning immunization culture into succinct, actionable bullet points.
We hope that your practice will take some time this week to
reflect on the importance of infant immunizations and the profound impact these
vaccines have had in reducing vaccine preventable diseases. Happy National
Infant Immunization Week!
Calibration testing should be done every one
to two years or according to the manufacturer’s suggested timeline. TMDs can
experience a “drift” over time, affecting their accuracy. This testing ensures
the accuracy of the device continues to conform to nationally-accepted
If you need to replace the temperature
monitoring device at your practice or if the cost of calibration testing
outweighs the cost of purchasing a new device, CPP members can access a
discount on LogTag Vaccine Temperature Monitoring Kits. Simply contact the CPP office at mailto:email@example.com
for more information.
As announced at the ACIP meeting last week, supply of the pediatric formulation of Merck’s Recombivax HB will be returning to the private sector. The following vaccine presentations will be available for purchase beginning March 9, 2020:
At this time, the adult formulations of Recombivax HB are
still unavailable. You can keep up on supply updates by visiting the Merck
Supply Status website. Remember, CPP members can access a discount on
Dynavax’s Heplisav-B, a 2-dose hepatitis B vaccine series for adult
patients. To participate in this discount opportunity, contact the CPP
office to request an opt-in form. Once your practice is linked to the
CPP member discount, doses can be purchased
through an authorized distributor
If you have any questions or would like additional information, please contact the CPP Office at 614-722-2145 or your Merck representative.
The immunization schedules for 2020 recently
published by the Center for Disease Control (CDC) four recommendations for
vaccination based on shared clinical
decision-making. These vaccines are:
Meningococcal B (MenB) vaccination
for adolescents and young adults aged 16–23 years
Human papillomavirus (HPV)
vaccination for adults aged 27–45 years
Pneumococcal conjugate vaccination
(PCV13) for adults aged 65 years and older who do not have an
immunocompromising condition, cerebrospinal fluid leak, or cochlear implant
Hepatitis B (HepB) vaccination for
adults age 60 years and older with diabetes mellitus
But what is a shared clinical decision-making
recommendation? According to the CDC, an immunization is given this designation
when it is not indicated for all members of a population. The vaccination may
benefit some members of the age or risk group, but broad vaccination of people
in that group is unlikely to have population-level impacts. For shared clinical
decision-making immunizations, patients and providers should discuss the
potential benefits of vaccination and come to a personalized decision together.
Over the next month, we will examine the
individual immunizations that the ACIP recommends for shared clinical
The HPV vaccination is routinely recommended
for ages 11 or 12 with catch-up recommendations for those not vaccinated on
In June 2019, the ACIP recommended shared
clinical decision-making for HPV vaccination of adults aged 27–45 years. According
to the ACIP
Shared Clinical Decision-Making Recommendations, HPV acquisition generally
occurs soon after first sexual activity. Vaccine effectiveness is lower in
older age groups because of prior infections and lower risk of exposure (for
example, among persons who are in a long-term, mutually monogamous sexual
partnership). The ACIP recommended shared clinical decision-making rather than
catch-up vaccination because most adults in this age group would have no or
minimal benefits from vaccination. However, some individuals who are not already
immune to HPV through vaccination or natural infection (e.g., a previously
unvaccinated person who has never had sex) and who might be at risk for
acquiring a new HPV infection in the future (e.g., plans to have sex with a new
partner in the future) might benefit from vaccination.
A detailed explanation of the ACIP’s
recommendation and considerations for shared clinical decision making regarding
HPV vaccination of adults aged 27 through 45 years can be found on the HPV Updated
Both the National Foundation for Infectious
Diseases and the American Academy of Pediatrics have a wealth of resources to
aid in improving HPV vaccination rates. These include clinical resources,
printable documents for patient education, videos, and webinars. Below is an
overview of the resources provided by each organization.
Make necessary changes in your
practice to improve HPV vaccination rates.
The site includes a collection
of printable resources for clinicians, caregivers, and preteens/teens.
Materials for caregivers are available in multiple languages. It also contains
for implementing a change in your office related to the HPV vaccine. The
plan uses the Plan, DO, Study, Act (PDSA) improvement cycle, and provides
resources for introducing standing orders, giving strong recommendations, using
reminder recall systems, and more. In addition, there are teaching
tools including a communication simulation app and slide decks to be used
in grand rounds or resident training.
The NFID’s Best Practices to Increase HPV
Immunization Rates contains resources to increase HPV vaccination rates and
educational tools to share with patients. Resources include a Call
to Action published by the NFID and links to the Association of
Immunization Managers conference calls discussing increasing vaccination
rates. In addition, there are links to standing orders for both adults and
children and teens, articles and videos, and infographics. Finally, the NFID
houses a collection of information titled Communication on
HPV Vaccination. These resources include a guide to addressing parents’
questions, various fact sheets, and public service announcements.
Both organizations provide useful information
to increase HPV vaccination rates in your practice. If you are working on
improving HPV rates, why not take a look at CPP’s Second Dose Program
where you can earn a grant for raising rates on the second dose administration
of several vaccine series.
Measles is a highly contagious infectious
disease that can result in severe complications and even death. According to
the Centers for Disease Control and Prevention (CDC), more than 1,200
individual cases of measles have been confirmed in 2019 in 31 states—the
largest number of cases since measles was eliminated in the US in 2000.
To help combat measles and raise awareness, The
National Foundation for Infectious Diseases (NFID) has compiled a wealth of
information concerning Measles. They have launched a campaign to raise
awareness about the risks associated with measles and the importance of
prevention through vaccination. This Measles Awareness Toolkit includes short
videos and infographics to share via social media.
Below are helpful resources your practice can use to educate and raise awareness about measles.
This Thursday, January 30, Sanofi Pasteur
presents a webcast on influenza prevention. Join Dr. John J Russell, Clinical
Professor of Family and Community Medicine at Thomas Jefferson University, and
a panel of subject matter experts.
Program objectives include:
Examine the medical burden of
influenza and its economic impact in adults 50 years of age and older
Explore the role that influenza
can play in exacerbation of chronic conditions, leading to adverse outcomes
Review clinical evidence of two
influenza vaccines that were compared to standard-dose influenza vaccines in
There are three times to choose from: 12:15pm,
1:30pm, and 3:15pm EST.